L2 Bio looking for Principal Investigators for its Phase 2B adipose stem cell trial for Crohn’s Disease
The FDA has recently approved them for what appears to be an expanded adipose MSC trial, looking for GI experienced physicians.
The trial will examine IV administration of adipose-derived stem cells (ADSCs) from either the patient or a first-degree relative.
“I have had over 100 submissions, approvals and clearances for my clients with the FDA over the past 20 plus years. This Crohn’s trial and the anticipated outcomes maybe one of the most exciting trials I have been involved with,” said Mukesh Kumar, PhD, Regulatory Advisor for L2 Bio.
L2 is looking for MDs and DOs specializing in gastrointestinal disorders such as Chron’s, Inflammatory Bowel Disease, etc.
Interested physicians are invited to submit their most recent Curriculum Vitae (CV) along with a brief paragraph detailing their relevant experience with Crohn’s Disease, IBD, or related conditions at www.L2Bio.com. Applicants will also be asked to complete five short screening questions.
